Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Osteoprotegerin ligand: a regulator of immune responses and bone physiology.

× No keyword cloud information.

41 in total

1. Osteolysis and cancer.

Authors: D Goltzman
Journal: J Clin Invest Date: 2001-05 Impact factor: 14.808

2. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.

Authors: Z J Zhai; H W Li; G W Liu; X H Qu; B Tian; W Yan; Z Lin; T T Tang; A Qin; K R Dai
Journal: Br J Pharmacol Date: 2014-02 Impact factor: 8.739

3. Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.

Authors: Alessandra Colombini; Giovanni Lombardi; Emanuela Galliera; Giada Dogliotti; Pietro Randelli; Alexander Meerssemann; Giuseppe Mineo; Paolo Cabitza; Massimiliano Marco Corsi
Journal: Int Orthop Date: 2010-07-11 Impact factor: 3.075

Review 4. Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration.

Authors: Zohara Sternberg
Journal: Neuromolecular Med Date: 2018-02-10 Impact factor: 3.843

5. RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease.

Authors: Frank Christoph; Frank König; Steffen Lebentrau; Burkhard Jandrig; Hans Krause; Romy Strenziok; Martin Schostak
Journal: World J Urol Date: 2017-12-04 Impact factor: 4.226

6. Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis.

Authors: Saba Abdi; Rawan A Binbaz; Abdul Khader Mohammed; Mohammed G A Ansari; Kaiser Wani; Osama E Amer; Abdullah M Alnaami; Naji Aljohani; Nasser M Al-Daghri
Journal: Genes (Basel) Date: 2021-01-29 Impact factor: 4.096

7. Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.

Authors: Kazu Okuma; Kevin P Dalton; Linda Buonocore; Elizabeth Ramsburg; John K Rose
Journal: J Virol Date: 2003-08 Impact factor: 5.103

Osteoprotegerin ligand: a regulator of immune responses and bone physiology.